Michelle Jones

Michelle A. Jones has over 20 years of experience in clinical operations and management. Michelle A. is currently serving as the Sr. Director of Clinical Development at Bold Therapeutics Inc. since April 2019. Prior to this, they worked as a Clinical Operations Consultant for Confidential Clientele starting in November 2015. Michelle A. also held the position of Vice President of Clinical Operations at Symvivo Corporation from June 2020 to May 2023. Additionally, Michelle worked as the Associate Director of Clinical Operations at Qu Biologics Inc. from July 2017 to October 2021. Michelle A. also had managerial roles at CIHR Canadian HIV Trials Network from February 2014 to November 2015 and from January 2011 to February 2014. Before that, they worked as the Manager of Clinical and Regulatory Affairs at GI Research Institute from August 2008 to January 2011 and at Protiva Biotherapeutics from January 2005 to August 2008. Michelle started their career as a Clinical Research Nurse at the University of British Columbia in May 2001 and later became the Clinical Research Manager from July 2003 to January 2005.

Michelle A. Jones holds an MBA in Management of Biotechnology from Simon Fraser University, which was obtained from 2010 to 2012. Prior to that, they completed a Graduate Diploma in Business Administration from Simon Fraser University between 2007 and 2009. Michelle also has a Master of Science in Nursing (M.Sc., RN) from McGill University, earned from 1998 to 2001. Michelle A.'sundergraduate degree is a Bachelor of Science (B.Sc.) in Biochemistry from Simon Fraser University, which they obtained from 1993 to 1998.